NASDAQ · Biotechnology

Cognition Therapeutics Inc (CGTX)

$0.58 -3.06%
29 Oversold Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$1.04-44.02%

Company profile

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York.

SectorHealthcare
IndustryBiotechnology
Market cap$64.41M
P/E ratioNone
EPS$-0.16
Beta1.799
Dividend yield0.00%
52-week high$1.81
52-week low$0.55

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for CGTX

An email when CGTX closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 5:43 AM EST